Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Nottingham Further Invest In Green Chemistry Laboratory

Published: Thursday, May 30, 2013
Last Updated: Thursday, May 30, 2013
Bookmark and Share
The School of Chemistry at the University of Nottingham (UK) has placed a sizeable order with Asynt to upgrade their undergraduate teaching facilities.

The School of Chemistry at the University of Nottingham is one of the leading Chemistry departments in the UK and is recognised internationally for its world leading research portfolio, excellence in teaching and extensive engagement with Industry. Its expertise spans the spectrum of modern chemical technology including synthesis, analysis and characterisation, ranging from the core chemistry disciplines to areas at the interface with biological sciences and engineering (sustainable chemical processing). In 2012 GlaxoSmithKline (GSK) and The University of Nottingham formalised a collaboration to establish a new laboratory to accommodate a Centre of Excellence for sustainable chemistry, and to construct an innovative carbon neutral sustainable chemistry facility.

David Chambers-Asman, Director of Operations & Administration at the School of Chemistry commented 'In line with Nottingham's commitment to develop ‘green and sustainable’ chemistry methodologies, we wanted to find a safe, more environmentally friendly alternative to heated oil baths for our undergraduates to learn about organic synthesis'.

He added 'After reviewing the market we elected to invest in Asynt DrySyn Scholar heating block systems because of their robustness, enhanced operator safety features and ease-of-use - making them the ideal for our organic synthesis'. 'As we teach hundreds of students in each year of our undergraduate Chemistry courses using, heated oil baths presented a risk to our students (through accidental spillage) and involved periodic requirement to dispose of large quantities of oil - a risk and environmental burden eliminated by using the DrySyn Scholar Plus'.

Specifically designed for safety conscious teaching laboratories - the DrySyn Scholar Plus kit enables single 50ml, 100ml or 250ml round bottom flask reactions to be performed safely without the mess or inherent hazards of a hot oil bath or heating mantle. Prominent permanently fixed lifting handles ensure moving even hot reaction blocks are easy, fast and safe. Compatible with almost any magnetic hotplate stirrer, the low thermal mass design of the DrySyn Scholar minimises both power consumption and reaction heat-up time.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nottingham in €196 Million European Drug Discovery Drive
Nottingham chemists are taking part in European research programme to speed up the discovery of new drugs.
Friday, February 08, 2013
Licence to go Where no Chemist has Gone Before
Scientists at The University of Nottingham have overcome one of the significant research challenges facing electrochemists. For the first time they have found a way of probing right into the heart of an electrochemical reaction.
Monday, September 28, 2009
DICE — Leading the Way in Chemistry and Engineering
The University of Nottingham is set to become a world leader in ‘clean’ chemistry and engineering with the opening of a new multi-million pound research initiative.
Tuesday, January 15, 2008
Nottingham Faculty and Students Gain a New NMR Tool with ACD/Labs Software
Nottingham University advances NMR desktop capabilities through the acquisition of ACD/2D NMR Processor.
Thursday, December 07, 2006
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos